FIRST LIGHT ACQUISITION GROUP, INC.

Company

Calidi Biotherapeutics, Inc.

Filed

September 24, 2021

Accession Number

0000902664-21-004327

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →